ZAGREB, Jan 31 (Hina) - Croatia's drugs company Pliva said on Friday it had bought the Spanish pharmaceutical company Edigen, which is based in Madrid.
ZAGREB, Jan 31 (Hina) - Croatia's drugs company Pliva said on Friday
it had bought the Spanish pharmaceutical company Edigen, which is
based in Madrid. #L#
The previous owners -- Farmadis.Alcala SL and Espariola de
Desarrollo e Impulso Farmaceutico SA -- sold the entire stock in
Edigen for EUR9.3 million.
The purchase did not include the production facilities.
Edigen's manufacturing portfolio includes some of the most
requested generic medicines in Spain.
Pliva's goal is to become one of the principal manufacturers of such
medicines in Spain, while Edigen will become richer for numerous
generics Pliva makes on its own.
In order to increase Pliva's recognisability in Spain, all Edigen
products, as well as those currently being patented, will bear
Pliva's logo.
Edigen was established in 1997 and is one of the initiators of
generic medicine business in Spain. Currently it is ranked 12th on
the Spanish market of such medicines, with EUR260 million generated
in 2002.
(hina) ha